Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 213.00
Bid: 211.50
Ask: 213.50
Change: 2.00 (0.95%)
Spread: 2.00 (0.946%)
Open: 207.00
High: 213.50
Low: 207.00
Prev. Close: 211.00
AMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

19 Dec 2011 11:58

RNS Number : 2390U
Advanced Medical Solutions Grp PLC
19 December 2011
 



19 December 2011

 

Advanced Medical Solutions Group plc

("AMS" or the "Company")

 

Result of General Meeting

 

The Board of AMS (AIM: AMS), the global medical technology company, is pleased to announce that the Resolutions proposed at the General Meeting held today at 11.00 a.m. at the offices of Investec Bank plc, 2 Gresham Street, London EC2V 7QP, in connection with the proposed Placing to raise approximately £34.0 million for the proposed acquisition of RESORBA announced on 2 December 2011, were duly passed without amendment.

 

The Placing remains conditional upon the Placing Agreement becoming unconditional in all respects and upon Admission.

 

Application has been made to AIM for the Admission of 48,214,415 ordinary shares of 5 pence each in connection with the Placing and Acquisition. It is expected that Admission will become effective on 20 December 2011 and that dealings in the New Ordinary Shares will commence at 8.00 a.m. on 20 December 2011.

 

The New Ordinary Shares (in uncertificated form) are expected to be credited to CREST accounts on or around 8.00 a.m. on 20 December 2011 and definitive share certificates for the New Ordinary Shares (in certificated form) are expected to be despatched to certificated shareholders by no later than 4 January 2012.

 

The New Ordinary Shares will be issued credited as fully paid and will, on issue, rank equally in all respects with the Existing Ordinary Shares, including the right to receive all dividends or other distributions made, paid or declared after Admission.

 

On Admission, the Company's issued share capital will consist of 203,516,367 Ordinary Shares.

 

For further information, please contact:

Advanced Medical Solutions Group plc

Chris Meredith, Chief Executive Officer

Mary Tavener, Finance Director

 

Tel: +44 (0) 1606 545508

Investec Bank plc (NOMAD) and Broker

Gary Clarence

Patrick Robb

Daniel Adams

Cara Griffiths

 

Tel: +44 (0) 20 7597 5970

Tavistock Communications

John West

Chris Munden

Andrew Dunn

 

Tel: +44 (0) 20 7920 3150

 

Investec Bank plc, which is authorised and regulated in the United Kingdom by the FSA, is acting as nominated adviser, broker and underwriter to AMS in relation to the Placing and Admission and is not acting for any other persons in relation to the Placing and Admission. Investec Bank plc is acting exclusively for AMS and for no one else in relation to the matters described in this announcement and is not advising any other person and accordingly will not be responsible to anyone other than AMS for providing the protections afforded to clients of Investec Bank plc, or for providing advice in relation to the contents of this announcement or any matter referred to in it. The responsibilities of Investec Bank plc as AMS's nominated adviser and broker under the AIM Rules for Companies and the AIM Rules for Nominated Advisers are owed solely to the London Stock Exchange and are not owed to AMS or to any Director, Shareholder or any other person, in respect of any decision to acquire or dispose of shares in the capital of AMS in reliance on any part of this announcement, or otherwise.

 

No liability is accepted by Investec Bank plc nor does it make any representation or warranty, express or implied, in relation to, the contents of this announcement, including its accuracy, completeness or verification or for any other statement made or purported to be made by it, or on its behalf, in connection with the Company and the Placing and accordingly Investec Bank plc disclaims all and any responsibility or liability whether arising in tort, contract or otherwise which it might otherwise have in respect of this announcement or any such statement. Investec Bank plc has not authorised the contents, or any part, of this announcement. Investec Bank plc may, in accordance with applicable legal and regulatory provisions, engage in transactions in relation to the Ordinary Shares (including the Placing Shares) and/or related instruments for its own account for the purposes of hedging its underwriting exposure or otherwise. Except as required by applicable law or regulation, Investec Bank plc does not propose to make any public disclosure in relation to any such transactions.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFKLFFFLFEFBE
Date   Source Headline
30th Jul 20197:00 amRNSFDA approval for two advanced woundcare ranges
28th Jun 20192:23 pmRNSTotal Voting Rights
21st Jun 20197:00 amRNSTrading Update
5th Jun 20195:29 pmRNSResult of AGM
5th Jun 20197:00 amRNSNotice of AGM
31st May 20193:10 pmRNSTotal Voting Rights
14th May 20197:00 amRNSIDE received for LiquiBand Fix8 in US
30th Apr 20194:56 pmRNSTotal Voting Rights
30th Apr 20199:40 amRNSNotice of Annual General Meeting and Annual Report
29th Apr 20195:27 pmRNSDirector/PDMR Shareholding
4th Apr 201910:16 amRNSDirector/PDMR Shareholding
27th Mar 20197:00 amRNSHolding(s) in Company
13th Mar 20197:00 amRNSUnaudited preliminary results
6th Mar 20199:13 amRNSBlock listing Interim Review
4th Mar 20192:24 pmRNSHolding(s) in Company
19th Feb 20197:00 amRNSNotice of Results
12th Feb 20194:23 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSAcquisition of Sealantis
31st Dec 20187:00 amRNSManagement Change
31st Dec 20187:00 amRNSTotal Voting Rights
20th Dec 20187:00 amRNSFix8 approved in Europe
18th Dec 20187:00 amRNSTrading Update
30th Nov 20181:40 pmRNSTotal Voting Rights
9th Nov 20183:06 pmRNSHoldings in Company
6th Nov 20184:33 pmRNSApplication for Admission
2nd Nov 201811:13 amRNSHolding(s) in Company
31st Oct 20185:20 pmRNSTotal Voting Rights
17th Sep 20184:30 pmRNSHolding(s) in Company
12th Sep 20187:00 amRNSInterim Results
31st Aug 20184:08 pmRNSApplication for Admission
10th Aug 20187:00 amRNSFDA approval for two woundcare portfolio dressings
7th Aug 20185:22 pmRNSHoldings in Company
27th Jul 20187:00 amRNSNotice of Interim Results
26th Jul 20183:23 pmRNSHoldings in Company
25th Jul 20182:26 pmRNSHoldings in Company
18th Jul 201812:28 pmRNSHolding(s) in Company
5th Jul 20187:00 amRNSTrading Update
29th Jun 20183:42 pmRNSTotal Voting Rights
28th Jun 20184:36 pmRNSDirector/PDMR Shareholding
11th Jun 20185:12 pmRNSDirector/PDMR Shareholding
6th Jun 201812:15 pmRNSResult of AGM
6th Jun 20187:00 amRNSNotice of AGM and Management Change
31st May 20183:49 pmRNSTotal Voting Rights
3rd May 20186:29 pmRNSDirector/PDMR and PCA Shareholding
3rd May 20185:12 pmRNSDirector/PDMR and PCA Shareholding
3rd May 201812:27 pmRNSDirector Declaration
30th Apr 20185:02 pmRNSTotal Voting Rights
26th Apr 20187:00 amRNSNotice of Annual General Meeting and Annual Report
18th Apr 20189:45 amRNSDirector/PDMR and PCA Shareholding
5th Apr 20185:46 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.